Practice Companion for Substance Use Disorder

This trial aims to create and test a guide, called the Practice Companion, to assist clinicians in supporting young people who use substances like opioids and cannabis. The guide will focus on overdose prevention and address mental health needs, as well as social factors like housing instability. Young people who have used drugs or alcohol in the past year and are receiving care at a participating site may be suitable candidates. The trial will evaluate the guide's usefulness and relevance for youth and their families. Findings will inform a larger future study on its effectiveness. As an unphased trial, this study offers participants the chance to contribute to developing a potentially impactful resource for youth substance use prevention.

Research has shown that effective ways to help young people with substance use include harm reduction, preventing overdoses, and using medications to treat addiction. These methods have been tested in various settings and are generally well-received by patients. For instance, naloxone is widely accepted for preventing overdoses and has a strong safety record. Take-home drug testing strips also serve as a safe and effective tool for managing substance use.

The "practice companion" is being developed to tailor these approaches to young people's specific needs. Although no direct safety data exists for this "practice companion," it incorporates well-researched methods safely used in adults and now adapted for younger individuals.

Researchers are excited about the Practice Companion for Substance Use Disorder because it offers a holistic and youth-centered approach to treatment. Unlike standard options that may focus solely on stopping substance use, this method provides comprehensive care by addressing overdose prevention with tools like naloxone and take-home drug testing strips, alongside harm reduction education. It also supports mental health and substance use issues with non-stigmatizing, family-friendly guidance, tailored specifically for young people aged 14 to 24. This personalized and inclusive approach aims to meet individual needs more effectively than traditional treatments.

Research has shown that community programs for substance use problems often work better than having no program at all. These programs help individuals reduce substance use, enhance mental health, and reconnect with their communities. This trial tests the Practice Companion as an experimental treatment. It incorporates research-based approaches such as harm reduction and overdose prevention, which have demonstrated slightly better results than standard care. These treatments are particularly important for young people, who often encounter unique challenges with substance use. Addressing both substance use and mental health together is crucial for long-term success.⁶⁷⁸⁹¹⁰